Princeton Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.22M | Sell |
3,378
-309
| -8% | -$106K | 0.28% | 48 |
|
|
2026
Q1 | $1.3M | Buy |
3,687
+17
| +0.5% | +$6.06K | 0.35% | 44 |
|
|
2025
Q4 | $1.2M | Sell |
3,670
-26
| -0.7% | -$8.25K | 0.31% | 44 |
|
|
2025
Q3 | $1.04M | Sell |
3,696
-664
| -15% | -$193K | 0.28% | 47 |
|
|
2025
Q2 | $1.22M | Sell |
4,360
-208
| -5% | -$58.9K | 0.36% | 43 |
|
|
2025
Q1 | $1.42M | Sell |
4,568
-215
| -4% | -$63.5K | 0.5% | 38 |
|
|
2024
Q4 | $1.25M | Sell |
4,783
-1,324
| -22% | -$393K | 0.39% | 39 |
|
|
2024
Q3 | $1.97M | Sell |
6,107
-2,624
| -30% | -$858K | 0.62% | 32 |
|
|
2024
Q2 | $2.73M | Sell |
8,731
-478
| -5% | -$140K | 0.89% | 23 |
|
|
2024
Q1 | $2.62M | Buy |
9,209
+196
| +2% | +$57.4K | 0.95% | 23 |
|
|
2023
Q4 | $2.6M | Sell |
9,013
-75
| -0.8% | -$20.4K | 1.05% | 21 |
|
|
2023
Q3 | $2.44M | Sell |
9,088
-895
| -9% | -$223K | 1.13% | 21 |
|
|
2023
Q2 | $2.22M | Sell |
9,983
-38
| -0.4% | -$8.82K | 0.92% | 26 |
|
|
2023
Q1 | $2.42M | Buy |
10,021
+370
| +4% | +$90.8K | 1.04% | 28 |
|
|
2022
Q4 | $2.53M | Buy |
9,651
+3,502
| +57% | +$939K | 1.13% | 29 |
|
|
2022
Q3 | $1.39M | Buy |
6,149
+67
| +1% | +$16.2K | 0.61% | 37 |
|
|
2022
Q2 | $1.48M | Sell |
6,082
-35
| -0.6% | -$8.58K | 0.57% | 41 |
|
|
2022
Q1 | $1.48M | Sell |
6,117
-88
| -1% | -$20.2K | 0.46% | 47 |
|
|
2021
Q4 | $1.4M | Buy |
6,205
+2
| +0% | +$422 | 0.4% | 52 |
|
|
2021
Q3 | $1.32M | Hold |
6,203
| – | – | 0.42% | 52 |
|
|
2021
Q2 | $1.51M | Buy |
6,203
+94
| +2% | +$23.1K | 0.47% | 46 |
|
|
2021
Q1 | $1.52M | Buy |
6,109
+22
| +0.4% | +$5.25K | 0.51% | 47 |
|
|
2020
Q4 | $1.4M | Buy |
6,087
+526
| +9% | +$121K | 0.5% | 48 |
|
|
2020
Q3 | $1.41M | Buy |
5,561
+415
| +8% | +$103K | 0.57% | 44 |
|
|
2020
Q2 | $1.21M | Hold |
5,146
| – | – | 0.54% | 43 |
|
|
2020
Q1 | $1.22M | Buy |
5,146
+163
| +3% | +$35.6K | 0.63% | 37 |
|
|
2019
Q4 | $1.14M | Sell |
4,983
-67
| -1% | -$14.8K | 0.51% | 40 |
|
|
2019
Q3 | $977K | Buy |
5,050
+27
| +0.5% | +$5.18K | 0.47% | 42 |
|
|
2019
Q2 | $926K | Buy |
5,023
+2,044
| +69% | +$366K | 0.45% | 44 |
|
|
2019
Q1 | $566K | Buy |
2,979
+2,445
| +458% | +$467K | 0.29% | 56 |
|
|
2018
Q4 | $104K | Buy |
534
+475
| +805% | +$92.7K | 0.06% | 115 |
|
|
2018
Q3 | $12K | Sell |
59
-47
| -44% | -$9.26K | 0.01% | 222 |
|
|
2018
Q2 | $20K | Hold |
106
| – | – | 0.01% | 225 |
|
|
2018
Q1 | $18K | Buy |
+106
| New | +$19.5K | 0.01% | 219 |
|
|
2016
Q4 | $929K | Buy |
+6,354
| New | +$956K | 1.34% | 36 |
|
|
2016
Q1 | – | Sell |
-8,467
| Closed | -$1.37M | – | 76 |
|
|
2015
Q4 | $1.37M | Sell |
8,467
-299
| -3% | -$47K | 1.55% | 25 |
|
|
2015
Q3 | $1.21M | Sell |
8,766
-615
| -7% | -$96.9K | 1.38% | 37 |
|
|
2015
Q2 | $1.44M | Sell |
9,381
-1,743
| -16% | -$279K | 1.46% | 24 |
|
|
2015
Q1 | $1.78M | Buy |
11,124
+68
| +0.6% | +$10.7K | 1.73% | 7 |
|
|
2014
Q4 | $1.76M | Sell |
11,056
-2,826
| -20% | -$440K | 1.75% | 10 |
|
|
2014
Q3 | $1.95M | Sell |
13,882
-835
| -6% | -$109K | 1.78% | 11 |
|
|
2014
Q2 | $1.74M | Buy |
14,717
+64
| +0.4% | +$7.41K | 1.47% | 29 |
|
|
2014
Q1 | $1.81M | Sell |
14,653
-1,239
| -8% | -$150K | 1.52% | 20 |
|
|
2013
Q4 | $1.81M | Buy |
15,892
+125
| +0.8% | +$14.2K | 1.51% | 21 |
|
|
2013
Q3 | $1.76M | Sell |
15,767
-405
| -3% | -$43.9K | 1.61% | 12 |
|
|
2013
Q2 | $1.6M | Buy |
+16,172
| New | +$1.68M | 1.51% | 19 |
|
Other funds holding AMGN
Princeton Capital Management's AMGN Position: Q2 2026 in Review
Princeton Capital Management reduced its Amgen (AMGN) stake by 8.4% in Q2 2026, selling an estimated $106K and leaving 3,378 shares worth $1.22M. The position accounts for 0.28% of the portfolio, ranked #48.
Princeton Capital Management first reported a position in AMGN in Q2 2013 and has held it in 46 quarters since. The position peaked at $2.73M in Q2 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Princeton Capital Management held 3,378 shares of Amgen worth $1.22M as of Q2 2026.
- Princeton Capital Management sold 309 Amgen shares in Q2 2026, an estimated $106K.
- Amgen made up 0.28% of Princeton Capital Management's portfolio in Q2 2026, its #48 holding.
- Princeton Capital Management first reported a position in Amgen in Q2 2013 and has held it in 46 quarters since.
- Princeton Capital Management's Amgen position peaked at $2.73M in Q2 2024.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Princeton Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.